Crossmark Global Holdings’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,670
Closed -$232K 1349
2025
Q1
$232K Buy
1,670
+40
+2% +$6.21K ﹤0.01% 1202
2024
Q4
$253K Sell
1,630
-85
-5% -$14.4K ﹤0.01% 1117
2024
Q3
$313K Buy
+1,715
New +$254K 0.01% 1053
2023
Q3
Sell
-1,639
Closed -$292K 1289
2023
Q2
$292K Sell
1,639
-338
-17% -$62K 0.01% 1084
2023
Q1
$326K Buy
1,977
+338
+21% +$58.1K 0.01% 1007
2022
Q4
$258K Sell
1,639
-356
-18% -$54.2K 0.01% 1082
2022
Q3
$300K Buy
1,995
+59
+3% +$9.82K 0.01% 994
2022
Q2
$319K Sell
1,936
-80
-4% -$15.4K 0.01% 1005
2022
Q1
$449K Buy
2,016
+80
+4% +$17.9K 0.01% 954
2021
Q4
$459K Buy
1,936
+290
+18% +$67.7K 0.01% 934
2021
Q3
$384K Sell
1,646
-10
-0.6% -$2.1K 0.01% 1055
2021
Q2
$341K Sell
1,656
-79
-5% -$16.3K 0.01% 1114
2021
Q1
$356K Sell
1,735
-20
-1% -$4.22K 0.01% 1082
2020
Q4
$376K Sell
1,755
-420
-19% -$81.5K 0.01% 980
2020
Q3
$398K Sell
2,175
-130
-6% -$24.5K 0.01% 873
2020
Q2
$425K Buy
2,305
+149
+7% +$29.6K 0.01% 826
2020
Q1
$435K Sell
2,156
-150
-7% -$28.9K 0.02% 699
2019
Q4
$431K Buy
2,306
+517
+29% +$89K 0.01% 884
2019
Q3
$286K Buy
1,789
+50
+3% +$9.95K 0.01% 1079
2019
Q2
$438K Sell
1,739
-40
-2% -$9.27K 0.01% 871
2019
Q1
$426K Buy
1,779
+257
+17% +$61.6K 0.01% 904
2018
Q4
$349K Sell
1,522
-1,408
-48% -$347K 0.01% 975
2018
Q3
$828K Sell
2,930
-63
-2% -$18.5K 0.02% 688
2018
Q2
$879K Buy
2,993
+416
+16% +$114K 0.02% 650
2018
Q1
$650K Sell
2,577
-1,649
-39% -$388K 0.02% 774
2017
Q4
$913K Buy
4,226
+897
+27% +$182K 0.02% 677
2017
Q3
$619K Buy
+3,329
New +$581K 0.02% 829
2016
Q3
$619K Buy
+3,329
New +$401K 0.02% 829

Other funds holding ICUI

Crossmark Global Holdings's ICUI Position: Q2 2025 in Review

Crossmark Global Holdings sold out of ICU Medical (ICUI) in Q2 2025, closing a stake of 1,670 shares — an estimated $232K sold.

Crossmark Global Holdings first reported a position in ICUI in Q3 2016 and held it in 28 quarters. The position peaked at $913K in Q4 2017. 271 funds tracked by Wall St. Rank hold ICUI as of Q2 2025.

  • Crossmark Global Holdings reported no remaining ICU Medical position as of Q2 2025 after selling out during the quarter.
  • Crossmark Global Holdings sold 1,670 ICU Medical shares in Q2 2025, an estimated $232K.
  • Crossmark Global Holdings first reported a position in ICU Medical in Q3 2016 and held it in 28 quarters.
  • Crossmark Global Holdings's ICU Medical position peaked at $913K in Q4 2017.
  • 271 funds tracked by Wall St. Rank held ICU Medical as of Q2 2025.

Based on Crossmark Global Holdings's 13F filing for Q2 2025, filed 8 Aug 2025.